Snovitra
$ 41,00 – $ 327,00Price range: $ 41,00 through $ 327,00
Soolantra
$ 68,00 – $ 72,00Price range: $ 68,00 through $ 72,00
Solian
$ 89,00 – $ 745,00Price range: $ 89,00 through $ 745,00
Solian is an effective antipsychotic medication primarily used to manage symptoms associated with schizophrenia. It contains the active ingredient Amisulpride, which works by balancing specific neurotransmitters in the brain to improve mental clarity. This medication is highly effective at reducing positive symptoms such as hallucinations, delusions, and disorganized thinking. Additionally, Solian helps address negative symptoms like emotional withdrawal and a lack of motivation, supporting a more stable daily life. By providing comprehensive symptom control, this treatment assists individuals in maintaining better social functioning and long-term stability.
Active substance: amisulpride
SKU:
Solian
Category: AntiPsychotic
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Solian belongs to a group of medicines called atypical antipsychotics, which act primarily on central nervous system dopamine receptors. The active substance, amisulpride, modulates neurochemical transmission to assist in managing specific psychiatric and behavioral conditions. In the United States, pharmaceutical products containing amisulpride are dispensed in accordance with applicable federal and state regulations under the oversight of a qualified healthcare provider.
Because response to psychiatric treatments varies significantly among individuals, administration of this agent requires individual clinical assessment and continuous medical supervision. This document outlines the essential pharmacological characteristics, safety guidelines, and clinical parameters associated with Solian.
Pharmacological Profile and Basic Information
| Amisulpride |
| Atypical antipsychotic / Dopamine D2/D3 receptor antagonist |
| Oral tablet / Oral solution |
| Oral |
| Management of acute and chronic psychotic disorders |
| Store below 30°C (86°F) in a dry place protected from light |
Mechanism of action and What happens in the body
Mechanism of action: The pharmacological effect of Solian is driven by its selective affinity for human dopamine D2 and D3 receptor subtypes. Unlike conventional antipsychotic agents, amisulpride exhibits no significant affinity for serotonin (5-HT2A), histamine H1, alpha-adrenergic, or cholinergic receptors. At lower daily dosages, the drug preferentially blocks presynaptic D2 and D3 autoreceptors, which enhances dopaminergic neurotransmission and helps address negative symptoms. At higher therapeutic dosages, it blocks postsynaptic dopamine receptors in the limbic system, reducing positive psychotic manifestations.
What happens in the body (Pharmacokinetics): Following oral administration, amisulpride exhibits two absorption peaks: one occurring rapidly at approximately 1 hour post-dose, and a second peak occurring between 3 and 4 hours after intake. The absolute oral bioavailability of the compound is approximately 48%. Plasma protein binding is relatively low, measured at roughly 16% to 17%, indicating a minimal likelihood of displaceable protein-binding interactions. Amisulpride undergoes limited hepatic metabolism, with the majority of the dose eliminated unchanged through the kidneys via glomerular filtration and tubular secretion. The elimination half-life is approximately 12 hours. Consequently, renal function directly influences clearance rates, requiring dose modification in patients with impaired kidney performance.
What it’s used for and Dosing schedule
What it’s used for: Solian is primarily indicated for the treatment of acute and chronic schizophrenic disorders. Clinical indications encompass both positive symptoms (such as delusions, hallucinations, thought disorders, hostility, and suspiciousness) and negative symptoms (such as blunted affect, emotional and social withdrawal, and poverty of speech). In certain jurisdictions, low-dose regimens are utilized off-label for dysthymia or persistent depressive manifestations under strict clinical evaluation; any use outside approved labeling must be classified as an off-label application and conducted strictly under expert medical advice.
Dosing schedule: The dose is determined individually based on the patient’s clinical presentation, symptom severity, and renal function status. For acute psychotic episodes, recommended oral dosages typically range between 400 mg/day and 800 mg/day, administered in divided doses. In individual cases, doses may be titrated up to a maximum of 1200 mg/day under close monitoring. For patients presenting predominantly with negative symptoms, lower dosage schedules ranging from 50 mg/day to 300 mg/day are generally utilized. Oral doses up to 400 mg may be taken once daily, whereas daily doses exceeding 400 mg should be divided into two administrations. Dosing adjustments are mandatory for patients with renal impairment (creatinine clearance below 60 mL/min).
Safety Guidelines, Precautions, and Common Questions
Adverse reactions and Important precautions
Adverse reactions: Clinical trials and post-marketing surveillance identify several potential adverse reactions associated with amisulpride administration. Common side effects include extrapyramidal symptoms (such as tremor, rigidity, hypokinesia, akathisia, and hypersalivation), insomnia, anxiety, agitation, and gastrointestinal disturbances like constipation or nausea. Due to dopamine D2 blockade in the tuberoinfundibular pathway, hyperprolactinemia occurs frequently, potentially leading to galactorrhea, amenorrhea, gynecomastia, breast pain, and erectile dysfunction. Weight gain and orthostatic hypotension are also documented. Severe but less frequent adverse events include QT interval prolongation, cardiac arrhythmias (such as Torsades de Pointes), neuroleptic malignant syndrome (NMS), seizures, and venous thromboembolism.
Important precautions: Caution is warranted when prescribing Solian to patients with pre-existing cardiovascular disease, a personal or family history of QT prolongation, or electrolyte imbalances (such as hypokalemia or hypomagnesemia). Baseline and periodic electrocardiogram (ECG) monitoring and serum electrolyte tests are recommended. Elderly patients with dementia-related psychosis treated with antipsychotic medications face an increased risk of mortality; Solian is not approved for dementia-related psychosis. Patients with a history of seizures require vigilant observation, as amisulpride may lower the seizure threshold. Abrupt withdrawal should be avoided to prevent acute withdrawal symptoms or rapid relapse.
Compatibility with other medicines: Co-administration of Solian with medications known to prolong the QT interval–such as Class IA antiarrhythmics (quinidine, disopyramide), Class III antiarrhythmics (amiodarone, sotalol), certain antihistamines, and other antipsychotics–is contraindicated or requires extreme caution. Concomitant use with drugs that induce bradycardia or electrolyte disturbances (e.g., loop diuretics) elevates cardiac risks. Amisulpride may antagonize the therapeutic effects of dopamine agonists (such as levodopa, ropinirole, or pramipexole). Central nervous system depressants, including narcotics, sedatives, and hypnotics, may potentiate sedative effects when combined with amisulpride.
What to avoid while taking it: Consumption of alcohol or alcohol-containing medications must be avoided during treatment with Solian, as ethanol potentiates the central nervous system depressant and hypotensive effects of amisulpride. Patients should exercise caution when operating machinery or driving vehicles until their individual tolerance and response to the medication have been fully established.
If you skip a dose: If a scheduled dose is missed, it should be taken as soon as remembered, unless it is nearly time for the next scheduled administration. Patients must not double the dose to compensate for a missed tablet, as this increases the risk of extrapyramidal and cardiovascular toxicity.
Special populations: In pediatric populations (children and adolescents under 18 years of age), safety and efficacy profiles have not been fully established; therefore, use is generally not recommended. In elderly individuals, dosage selection must proceed conservatively due to decreased renal clearance and heightened susceptibility to hypotension and sedation. During pregnancy, available clinical data are limited; Solian should be used during gestation only if the potential benefit outweighs the potential fetal risk. Neonates exposed to antipsychotics during the third trimester are at risk for extrapyramidal symptoms and withdrawal signs post-delivery. Breastfeeding is contraindicated during treatment, as amisulpride is excreted into human milk in significant amounts.
Storage and expiration: Solian tablets and oral solution should be stored at controlled room temperature below 30°C (86°F), away from excessive moisture, heat, and direct sunlight. Keep the container tightly closed and out of reach of children. Do not utilize the medication past the expiration date stated on the outer packaging.
Common questions
What specific baseline tests are required prior to initiating treatment with Solian?
Prior to starting therapy, healthcare providers typically perform a baseline electrocardiogram (ECG) to assess the QT interval, evaluate renal function via serum creatinine/blood urea nitrogen (BUN) assays, measure serum electrolytes (potassium and magnesium), and document baseline prolactin levels and body weight.
How is dose adjustment managed in patients with renal impairment?
Because amisulpride is primarily excreted unchanged by the kidneys, dosage must be scaled according to creatinine clearance (CrCl). For CrCl between 30 and 60 mL/min, the dose is generally reduced by half. For CrCl between 15 and 30 mL/min, the dose is reduced to one-third. In severe renal insufficiency (CrCl under 15 mL/min), use is contraindicated or restricted to specialized clinical oversight.
What signs indicate the onset of Neuroleptic Malignant Syndrome (NMS)?
NMS is a life-threatening neurological emergency characterized by hyperthermia (high fever), severe muscle rigidity, autonomic instability (irregular pulse, fluctuating blood pressure, diaphoresis), and altered mental state. Immediate discontinuation of Solian and urgent medical intervention are mandatory if these symptoms manifest.
Does Solian cause significant metabolic disturbances compared to other atypical antipsychotics?
Amisulpride displays a lower propensity for causing metabolic side effects (such as substantial weight gain, severe hyperglycemia, or marked dyslipidemia) compared to agents like olanzapine or clozapine. However, metabolic parameters and body weight should still be monitored periodically during prolonged administration.
Can Solian be stopped abruptly once symptoms resolve?
Abrupt cessation of Solian is not recommended due to the risk of rebound symptoms, acute psychotic relapse, or withdrawal phenomena such as nausea, insomnia, and movement abnormalities. Treatment discontinuation should proceed via gradual dose reduction under the direction of the prescribing physician.
This text is for informational purposes only and does not constitute individual medical advice.
Additional information
| Dosage |
50mg ,100mg |
|---|---|
| Package |
30 pills ,60 pills ,90 pills ,120 pills ,180 pills ,270 pills |
| Ενεργός Ουσία |
Related products
Flunil
$ 21,00 – $ 138,00Price range: $ 21,00 through $ 138,00
Active substance: Fluoxetine
More Details
This product has multiple variants. The options may be chosen on the product page
Geodon
$ 46,00 – $ 418,00Price range: $ 46,00 through $ 418,00
Active substance: Ziprasidone
More Details
This product has multiple variants. The options may be chosen on the product page
Kemadrin
$ 41,00 – $ 281,00Price range: $ 41,00 through $ 281,00
Active substance: procyclidine
More Details
This product has multiple variants. The options may be chosen on the product page
Nootropil
$ 30,00 – $ 363,00Price range: $ 30,00 through $ 363,00
Active substance: Piracetam
More Details
This product has multiple variants. The options may be chosen on the product page
Pim-800
$ 43,00 – $ 274,00Price range: $ 43,00 through $ 274,00
Active substance: Paracetamol
More Details
This product has multiple variants. The options may be chosen on the product page
Risperdal
$ 5,00 – $ 968,00Price range: $ 5,00 through $ 968,00
Active substance: Risperidone
More Details
This product has multiple variants. The options may be chosen on the product page
Valparin
$ 100,00 – $ 273,00Price range: $ 100,00 through $ 273,00
Active substance: Valproic Acid
More Details
This product has multiple variants. The options may be chosen on the product page
Zyprexa
$ 41,00 – $ 358,00Price range: $ 41,00 through $ 358,00
Active substance: Olanzapine
More Details
This product has multiple variants. The options may be chosen on the product page
